Cargando…
Recommending HPV vaccination at age 9 to reduce health disparities: Communication challenges and opportunities
The HPV vaccine is approved for children as young as age nine and recommended by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices routinely for ages 11–12. However, many U.S. adolescents do not complete the vaccine series until middle to late adolescence,...
Autores principales: | Coyne-Beasley, Tamera, Ortiz, Rebecca R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294731/ https://www.ncbi.nlm.nih.gov/pubmed/37067338 http://dx.doi.org/10.1080/21645515.2023.2178219 |
Ejemplares similares
-
Social marketing to promote HPV vaccination in pre-teenage children: Talk about a sexually transmitted infection
por: Cates, Joan R, et al.
Publicado: (2015) -
Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10
por: Kahn, Benjamin Z., et al.
Publicado: (2023) -
How to make effective HPV vaccine recommendations starting at age 9
por: Brewer, Noel T., et al.
Publicado: (2023) -
HPV vaccine recommendations by age: A survey of providers in federally qualified health centers
por: Lake, Paige, et al.
Publicado: (2023) -
Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13?
por: O’Leary, Sonja C., et al.
Publicado: (2023)